Volition

Curated by Signal

Developer of cancer diagnostic tests

Overview

Developer of cancer diagnostic tests. The Nu-Q is used for early cancer diagnostics by detecting nucleosome markers of cancer and early-stage cells in the blood. It has also developed vet cancer screening tests.

Key facts

Founded: 2019
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Proprio
Developer of visualization system for surgeries
Life Sciences TechnologySeattle, United States
PRASM
Blockchain-based platform offering lifestyle recommendations using bioinformatics
Life Sciences TechnologySan Francisco, United States
Cephalogics
Portable brain perfusion imaging system
Life Sciences TechnologyBoston, United States

About Volition

What does Volition do?

Developer of cancer diagnostic tests.

Where is Volition headquartered?

Volition is headquartered in San Francisco, United States.

When was Volition founded?

Volition was founded in 2019.

Which sector is Volition in?

Volition operates in Life Sciences Technology.

Who are Volition's competitors?

Companies similar to Volition include Proprio, PRASM, and Cephalogics.